Anal Fistula Plug, a Retrospective Study

Sponsor
Zhen Jun Wang (Other)
Overall Status
Completed
CT.gov ID
NCT04319861
Collaborator
(none)
207
1
1
126
1.6

Study Details

Study Description

Brief Summary

In this study, we retrospectively reviewed clinical data of patients who were treated with an anal fistula plug for trans-sphincteric anal fistulas, and evaluated the long-term therapeutic effect of an anal fistula plug and the risk factors impacting anal fistula healing. In addition, we assessed the effects of post-operative changes on anal function, as well as the risk factors affecting anal function.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Anal fistula plug procedure
N/A

Detailed Description

Treatment of anal fistulas, especially involving significant anal sphincters, continues to represent a challenge for surgeons. Surgery has been the mainstay of treatment, and the ideal goal of anal fistula treatment is to obliterate the fistulous tract, while preserving the anal sphincter and avoiding fecal incontinence. The anal fistula plug is a sphincter-sparing procedure that uses biological substances to close an anorectal fistula. Several studies have preliminarily shown that the anal fistula plug had advantages of simple and repeatable application, preservation of sphincter integrity, minimal patient discomfort, and subsequent surgical options if needed. The healing rate of anal fistula plug varied widely, which range from 14% to 88%, and no significant effect on anal function in the short term. Therefore, long-term observation and a large sample size are needed to evaluate the long-term healing rate of an anal fistula plug, and the effect on anal function. The aim of this study is to assess the long-term therapeutic effect of an anal fistula plug in patients with trans-sphincteric fistula-in-ano, as well as the impact on anal function.

Study Design

Study Type:
Interventional
Actual Enrollment :
207 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Long-term Clinical Results With the Use of an Anal Fistula Plug for the Treatment of Trans-sphincteric Anal Fistulas
Actual Study Start Date :
Aug 1, 2008
Actual Primary Completion Date :
Nov 20, 2018
Actual Study Completion Date :
Jan 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Anal fistula plug

The anal fistula plug procedure was performed as followings. A fistula probe was used to identify fistula tracts, and internal and external openings. Gentle mechanical debridement was performed with a blunt curette to remove the necrotic tissue with care not to enlarge the track, then hydrogen peroxide and sterile saline were used to repeatedly to irrigate the fistula. The anal fistutla plug was filled into the fistula, and sutured with a figure-of-eight 2-to-0 Vicryl suture to ensure the plug was fixed in the internal opening of the fistula, avoiding the anal fistula plug being extruded. Trimming the plug at the external fistula and the external opening was left open to ensure adequate drainage.

Procedure: Anal fistula plug procedure
A fistula probe was used to identify fistula tracts, and internal and external openings. Gentle mechanical debridement was performed with a blunt curette to remove the necrotic tissue with care not to enlarge the track, then hydrogen peroxide and sterile saline were used to repeatedly to irrigate the fistula. The anal fistutla plug was filled into the fistula, and sutured with a figure-of-eight 2-to-0 Vicryl suture to ensure the plug was fixed in the internal opening of the fistula, avoiding the anal fistula plug being extruded. Trimming the plug at the external fistula and the external opening was left open to ensure adequate drainage.

Outcome Measures

Primary Outcome Measures

  1. Healing rate [8 years postoperatively]

    The healing rate of anal fistula plug in 8 years postoperatively

Secondary Outcome Measures

  1. Anal function [8 years postoperatively]

    Cleveland Clinic Florida (Wexner) incontinence scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with trans-sphincteric anal fistula.

  • The case information was complete.

  • Not receive other treatment previously.

Exclusion Criteria:
  • Fistulas related to Crohn's disease, ulcerative colitis or anorectal tumors.

  • Underwent surgical incision and drainage for acute perianal infections within 3 months.

  • Multiple fistula tracts > 2.

  • Poor underlying condition and unable to tolerate surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Chaoyang Hospital, Capital Medical University Beijing Beijing China 100020

Sponsors and Collaborators

  • Zhen Jun Wang

Investigators

  • Study Director: Jiagang Han, Beijing Chao Yang Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zhen Jun Wang, Professor, Beijing Chao Yang Hospital
ClinicalTrials.gov Identifier:
NCT04319861
Other Study ID Numbers:
  • Plug 2020
First Posted:
Mar 24, 2020
Last Update Posted:
Mar 24, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zhen Jun Wang, Professor, Beijing Chao Yang Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 24, 2020